As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 5/13/24  Tonix Pharmas Holding Corp.       8-K:2,9     5/13/24   11:307K                                   Qes, LLC/FA              
 5/13/24  Tonix Pharmas Holding Corp.       10-Q        3/31/24   88:6.4M                                   Qes, LLC/FA              
 4/15/24  Tonix Pharmas Holding Corp.       ARS        12/31/23    1:772K                                   Qes, LLC/FA              
 4/15/24  Tonix Pharmas Holding Corp.       DEF 14A     5/22/24    1:628K                                   Qes, LLC/FA              
  4/5/24  Tonix Pharmas Holding Corp.       PRE 14A     5/22/24    1:628K                                   Qes, LLC/FA              
  4/1/24  Tonix Pharmas Holding Corp.       8-K:2,9      4/1/24   11:332K                                   Qes, LLC/FA              
  4/1/24  Tonix Pharmas Holding Corp.       10-K       12/31/23  110:10M                                    Qes, LLC/FA              
 3/29/24  Tonix Pharmas Holding Corp.       424B5                  1:431K                                   Qes, LLC/FA              
 3/29/24  Tonix Pharmas Holding Corp.       8-K:1,8,9   3/28/24   18:975K                                   Qes, LLC/FA              
 3/25/24  Tonix Pharmas Holding Corp.       8-K:7,8,9   3/25/24   11:237K                                   Quality Edgar - QES/FA   
 3/21/24  Tonix Pharmas Holding Corp.       8-K:7,8,9   3/21/24   12:762K                                   Quality Edgar - QES/FA   
 3/20/24  Tonix Pharmas Holding Corp.       8-K:7,8,9   3/20/24   11:229K                                   Qes, LLC/FA              
 3/19/24  Tonix Pharmas Holding Corp.       8-K:7,8,9   3/19/24   11:235K                                   Quality Edgar - QES/FA   
 3/11/24  Tonix Pharmas Holding Corp.       8-K:7,8,9   3/11/24   11:219K                                   Quality Edgar - QES/FA   
  3/7/24  Tonix Pharmas Holding Corp.       8-K:7,8,9    3/7/24   11:240K                                   Quality Edgar - QES/FA   
  3/6/24  Lederman Seth                     4/A        Dir.,Off.²  1:8K   Tonix Pharmas Holding Corp.       Qes, LLC/FA              
  3/6/24  Tonix Pharmas Holding Corp.       8-K:7,8,9    3/6/24   11:230K                                   Quality Edgar - QES/FA   
  3/5/24  Tonix Pharmas Holding Corp.       8-K:7,8,9    3/5/24   11:219K                                   Quality Edgar - QES/FA   
 2/29/24  Lederman Seth                     4          Dir.,Off.²  1:8K   Tonix Pharmas Holding Corp.       Qes, LLC/FA              
 2/29/24  Saenger Bradley                   4          Officer²    1:6K   Tonix Pharmas Holding Corp.       Qes, LLC/FA              

____________
¹	Filing/Form Types:  -K
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	424B5	Prospectus – Primary Offering or Shelf Securities – New Facts or Events.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	PRE 14A	Preliminary Proxy Statement — Schedule 14A.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.